abstract |
The present invention provides novel compounds of formula I that are antagonists of the C5a receptor. The compounds of the present invention are useful in the treatment of various C5a mediated diseases and disorders; therefore, the present invention provides methods for treating C5a mediated diseases using the novel compounds described herein and pharmaceutical compositions containing them. provide. |